By Abigail Townsend
Date: Thursday 24 Sep 2026
(Sharecast News) - Hikma Pharmaceuticals has named Rebecca Hall chief executive, the generic drugs specialist confirmed on Thursday.
| Director/PDMR Shareholding | 19-Dec-2025 | 15:50 | RNS |
| Director/PDMR Shareholding | 19-Dec-2025 | 15:43 | RNS |
| Hikma boosts injectables business with $300m deal | 29-May-2014 | Telegraph |
| MARKET REPORT: Shares jump as Hikma Pharmaceutic... | 08-May-2014 | Daily Mail |
| Hikma prepares return to Libya | 26-Aug-2011 | The Independent |
| Hikma deals pay off | 19-Mar-2008 | Telegraph |
| Hikma launches bid for generic drugs firm | 08-Oct-2007 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:Hikma | 02-Feb-2011 | The Independent |
| Questor:Hikma Pharmaceuticals | 23-Jul-2008 | Telegraph |
| Market Report: Respite for Rentokil after buyout... | 18-Jan-2008 | The Independent |
| Property sector buoyed by Laxey's £1bn opportuni... | 15-Jan-2008 | Telegraph |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 1,590.00p |
| Change Today | -35.00p |
| % Change | -2.15 % |
| 52 Week High | 1,851.00 |
| 52 Week Low | 1,191.00 |
| Volume | 264,752 |
| Shares Issued | 208.75m |
| Market Cap | £3,319.09m |
| Beta | 0.00 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 7 |
| Buy | 2 |
| Neutral | 1 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 11 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 13-Aug-26 | 19-Mar-26 |
| Paid | 17-Sep-26 | 30-Apr-26 |
| Amount | 38.00¢ | 48.00¢ |
| Time | Volume / Share Price |
| 16:35 | 181,847 @ 1,590.00p |
| 16:35 | 738 @ 1,590.00p |
| 16:35 | 725 @ 1,590.00p |
| 16:35 | 835 @ 1,590.00p |
| 16:35 | 1 @ 1,590.00p |
| CEO | Said Darwazah |
| Chair | Victoria Hull |
You are here: research